CEO Salary & Executive Compensation
Johnson & Johnson JNJ
CEO: Joaquin Duato · Pharmaceuticals · 131,900 employees
Joaquin Duato, CEO of Johnson & Johnson (JNJ), earned $12.0M in total compensation in 2025. Johnson & Johnson receives a Pay-for-Performance grade of B (68/100), with a CEO-to-worker pay ratio of 120:1 and a say-on-pay shareholder approval of 94.8%. The company's 3-year total shareholder return is +1.4%.
How Johnson & Johnson CEO Pay Compares
Joaquin Duato's $12.0M total compensation is 0% below the Pharmaceuticals industry median of $12.0M. The 120:1 CEO-to-worker pay ratio is 4% lower than the industry average of 125:1.
Total compensation for Joaquin Duato at Johnson & Johnson (JNJ) was $12.0M. Mid-cap public-company CEO packages tend to track this pattern — equity-heavy, multi-year vesting, performance-tied.
The CEO-to-median-worker pay ratio runs 120x. Lower ratios typically reflect companies with higher-paid workforces (financial services, technology, professional services) where the median worker pay denominator is itself substantial. Performance has been muted across the three-year window: 1.4% TSR, 5.2% revenue change. Stagnant performance combined with substantial CEO pay is the classic setup for proxy-advisor opposition on say-on-pay votes.
Shareholders supported the compensation package at 95% on the most recent say-on-pay vote. Solid support without overwhelming endorsement is the typical pattern for established public companies with conventional compensation programs. Johnson & Johnson operates in Pharmaceuticals with 131,900 employees and $85.2B in annual revenue, and currently carries a market capitalization of $370.0B. Pay comparisons across companies require controlling for these structural factors — a $20M package at a $10B-revenue tech company reads differently than the same package at a $1B-revenue industrial.
Source: SEC EDGAR — DEF 14A proxy statements for Johnson & Johnson (JNJ).
Compensation Breakdown
Joaquin Duato's $12.0M total compensation package for fiscal year 2025 includes $1.2M in base salary, $6.0M in stock awards, $1.4M in option awards, and $1.8M in bonus and non-equity incentives.
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2024 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2023 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2022 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Joaquin Duato, CEO of Johnson & Johnson (JNJ), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Frequently Asked Questions
Joaquin Duato, CEO of Johnson & Johnson (JNJ), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Johnson & Johnson has a Pay-for-Performance Score of B (68/100). The company's 3-year total shareholder return is +1.4%, and the say-on-pay shareholder vote passed with 94.8% approval.
The CEO-to-median-worker pay ratio at Johnson & Johnson is 120:1. The median worker at Johnson & Johnson earns $100K per year, while CEO Joaquin Duato earns $12.0M in total compensation.
Johnson & Johnson employs approximately 131,900 people. The company operates in the Pharmaceuticals industry within the Healthcare sector, generating $85.2B in annual revenue.